CIK: 0001591986
Total reported value
—
Reporting period: 2025-09-30 · Number of holdings: 1
Aquilo Capital Management, LLC disclosed 1 holdings in its latest 13F filing for the period ending 2025-09-30, with total reported value of — and a quarterly turnover rate of 0.0%.
Sector classification currently covers about 0% of this portfolio's disclosed value; the remainder includes holdings (e.g. unmapped tickers, options, or other security types) not yet covered by our sector mapping.
Sold out AMGN
Sold out 2655787D
Sold out ARWR
Sold out PTGX
Sold out KYMR
Sold out DTIL
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ✓ | Ikena Oncology INC | Stock-Other | — | — | — |
Performance for Q3 2026
—
Performance Last 4 Quarters
+7.5%
Based on 71% of reported portfolio value with available pricing
Not enough sector-mapped data yet
| Period | Holdings | Total value | Stability | Top holdings |
|---|---|---|---|---|
| 2025-09-30 | 1 | — | 0 | |
| 2025-06-30 | 1 | — | 0 | |
| 2025-03-31 | 13 | $55.8M | 100 | |
| 2024-12-31 | 15 | $66.3M | 0 | |
| 2024-09-30 | 14 | $131.9M | 0 | |
| 2024-06-30 | 13 | $103.7M | 0 | |
| 2024-03-31 | 10 | $133.4M | 0 | |
| 2023-12-31 | 10 | $160.5M | 0 | |
| 2023-09-30 | 12 | $110.4M | 0 | |
| 2023-06-30 | 13 | $180.5M | 0 | |
| 2023-03-31 | 12 | $241.3M | 0 | |
| 2022-12-31 | 13 | $266.2M | 0 | |
| 2022-09-30 | 15 | $277.4M | 0 | |
| 2022-06-30 | 13 | $293.0M | 0 | |
| 2022-03-31 | 14 | $680.4M | 0 | |
| 2021-12-31 | 14 | $881.7M | 0 | |
| 2021-09-30 | 14 | $550.6M | 0 | |
| 2021-06-30 | 15 | $384.9M | 61 | |
| 2021-03-31 | 17 | $553.4M | 65 | |
| 2020-12-31 | 17 | $481.2M | 100 | |
| 2020-09-30 | 17 | $944.6M | 83 | |
| 2020-06-30 | 14 | $495.9M | 78 | |
| 2020-03-31 | 14 | $256.6M | 51 | |
| 2019-12-31 | 12 | $266.2M | 77 | |
| 2019-09-30 | 11 | $142.0M | 77 | |
| 2019-06-30 | 13 | $288.1M | 38 | |
| 2019-03-31 | 14 | $225.9M | 81 | |
| 2018-12-31 | 14 | $206.6M | 0 |
Aquilo Capital Management, LLC's most significant position changes for 2025-09-30: Sold out: Amgen INC (AMGN); Sold out: Blueprint Medicines CORP (2655787D); Sold out: Arrowhead Pharmaceuticals In (ARWR); Sold out: Protagonist Therapeutics INC (PTGX); Sold out: Kymera Therapeutics INC (KYMR).
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | AMGN | Amgen INC | — | EXIT | Sold out |
| 2 | 2655787D | Blueprint Medicines CORP | — | EXIT | Sold out |
| 3 | ARWR | Arrowhead Pharmaceuticals In | — | EXIT | Sold out |
| 4 | PTGX | Protagonist Therapeutics INC | — | EXIT | Sold out |
| 5 | KYMR | Kymera Therapeutics INC | — | EXIT | Sold out |
| 6 | DTIL | Precision Biosciences INC | — | EXIT | Sold out |
| 7 | ARVN | Arvinas INC | — | EXIT | Sold out |
| 8 | RGNX | Regenxbio INC | — | EXIT | Sold out |
| 9 | TORCEUR | Adicet Bio INC | — | EXIT | Sold out |
| 10 | BCYC | Bicycle Therapeutics Plc-adr | — | EXIT | Sold out |
| 11 | ✓ | Immatics NV | — | EXIT | Sold out |
| 12 | RPTX | Repare Therapeutics INC | — | EXIT | Sold out |
| 13 | ZYME | Zymeworks INC | — | EXIT | Sold out |
| 14 | ✓ | Ikena Oncology INC | — | — | Unchanged |
| Period | Filed | Type | EDGAR |
|---|---|---|---|
| 2025-09-30 | 2025-11-12 | 13F-HR | View on EDGAR |
| 2025-06-30 | 2025-08-06 | 13F-HR | View on EDGAR |
| 2025-03-31 | 2025-05-15 | 13F-HR | View on EDGAR |
| 2024-12-31 | 2025-02-14 | 13F-HR | View on EDGAR |
| 2024-09-30 | 2024-11-14 | 13F-HR | View on EDGAR |
| 2024-06-30 | 2024-08-14 | 13F-HR | View on EDGAR |
| 2024-03-31 | 2024-05-15 | 13F-HR | View on EDGAR |
| 2023-12-31 | 2024-02-14 | 13F-HR | View on EDGAR |
| 2023-09-30 | 2023-11-14 | 13F-HR | View on EDGAR |
| 2023-06-30 | 2023-08-14 | 13F-HR | View on EDGAR |
| 2023-03-31 | 2023-05-15 | 13F-HR | View on EDGAR |
| 2022-12-31 | 2023-02-14 | 13F-HR | View on EDGAR |
| 2022-09-30 | 2022-11-14 | 13F-HR | View on EDGAR |
| 2022-06-30 | 2022-08-15 | 13F-HR | View on EDGAR |
| 2022-03-31 | 2022-05-16 | 13F-HR | View on EDGAR |
| 2021-12-31 | 2022-02-14 | 13F-HR | View on EDGAR |
| 2021-09-30 | 2021-11-15 | 13F-HR | View on EDGAR |
| 2021-06-30 | 2021-08-16 | 13F-HR | View on EDGAR |
| 2021-03-31 | 2021-05-17 | 13F-HR | View on EDGAR |
| 2020-12-31 | 2021-02-16 | 13F-HR | View on EDGAR |
| 2020-09-30 | 2020-11-16 | 13F-HR | View on EDGAR |
| 2020-06-30 | 2020-08-14 | 13F-HR | View on EDGAR |
| 2020-03-31 | 2020-05-15 | 13F-HR | View on EDGAR |
| 2019-12-31 | 2020-02-14 | 13F-HR | View on EDGAR |
| 2019-09-30 | 2019-11-14 | 13F-HR | View on EDGAR |
| 2019-06-30 | 2019-08-14 | 13F-HR | View on EDGAR |
| 2019-03-31 | 2019-05-15 | 13F-HR | View on EDGAR |
| 2018-12-31 | 2019-02-14 | 13F-HR | View on EDGAR |
Institutions with a similar AUM
CIK 0000048966
Total reported value
—
1 stks
2024-12-31
Stale — no recent filing
CIK 0000056822
Total reported value
—
1 stks
2019-12-31
Stale — no recent filing
CIK 0000083402
Total reported value
—
1 stks
2021-09-30
Stale — no recent filing